Share ownership Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 21:00:00 18/05/2026 BST			5-day change	1st Jan Change
436.58 ^USD	-0.08%		+1.57%	-3.70%

05-15	Daiwa Securities Adjusts PT on Vertex Pharmaceuticals to $555 From $561, Maintains Buy Rating	MT
05-13	Declaration of Voting Results by Vertex Pharmaceuticals Incorporated	CI

Share class: Vertex Pharmaceuticals Incorporated

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	253,805,417	253,282,622 ( 99.79 %)	0	99.79 %

Major shareholders: Vertex Pharmaceuticals Incorporated

Name	Equities	%	Valuation
Capital Research & Management Co. (World Investors) 10.1 %	25,695,015	10.1 %	10 982 M $
Capital Research & Management Co. (World Investors) 9.973 %	25,368,124	9.973 %	10 842 M $
Capital Research & Management Co. (Global Investors) 8.311 %	21,139,169	8.311 %	9 034 M $
Capital Research & Management Co. (Global Investors) 8.306 %	21,125,964	8.306 %	9 029 M $
Vanguard Capital Management LLC 7.484 %	19,036,076	7.484 %	8 136 M $
BlackRock Advisors LLC 7.005 %	17,818,088	7.005 %	7 615 M $
Vanguard Capital Management LLC 6.492 %	16,512,810	6.492 %	7 057 M $
STATE STREET CORPORATION 4.612 %	11,730,139	4.612 %	5 013 M $
JPMorgan Investment Management, Inc. 2.765 %	7,033,156	2.765 %	3 006 M $
Geode Capital Management LLC 2.414 %	6,139,621	2.414 %	2 624 M $
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░
░░░░░░░░░░░░░░░░░░░░░	░ ░░░	░░░░%	░░

Name	Equities	%	Valuation
Western Asset Management Company DTVM Ltda. 0.002623 %	26,685	0.002623 %	3 M $
BRAM - Bradesco Asset Management SA DTVM 0.00008 %	812	0.00008 %	86 299 $
XP Allocation Asset Management Ltda. 0.000022 %	225	0.000022 %	23 913 $

Breakdown by shareholder type

Institutional	104.54%
Other	9.53%
State Street Corp.	4.61%
Schweizerische Nationalbank	0.29%
Sumitomo Mitsui Trust Group, Inc.	0.24%
Individuals	0.24%
Manulife Financial Corp.	0.22%
Governments	0.13%
Swedbank AB	0.11%
SEI Investments Co.	0.09%
Danske Bank A/S	0.06%
ABN AMRO Bank NV	0.05%
Fifth Third Bancorp	0.03%
ING Groep NV	0.03%
Banco Bilbao Vizcaya Argentaria SA	0.02%
Zurich Insurance Group AG	0.02%
Skandinaviska Enskilda Banken AB	0.02%
The Bank of Nova Scotia	0.01%
The Allstate Corp.	0.01%
Pinnacle Financial Partners, Inc.	0.01%
Cullen/Frost Bankers, Inc.	0.01%
Silvercrest Asset Management Group, Inc.	0.01%
First Horizon Corp. (Tennessee)	0.01%

Based on 1000 largest holdings

Geographical origin of shareholders

United States	100.64%
United Kingdom	8.24%
Canada	1.95%
Norway	1.38%
France	1.33%
Switzerland	1.17%
Germany	0.78%
Japan	0.76%
Sweden	0.75%
Australia	0.52%
Netherlands	0.38%
Luxembourg	0.33%
South Korea	0.29%
Hong Kong	0.28%
Individuals	0.24%
Denmark	0.23%
Ireland	0.18%
Belgium	0.15%
Spain	0.13%
China	0.12%
Italy	0.08%
Finland	0.06%
Austria	0.05%
Russia	0.04%
Singapore	0.04%
Czech Republic	0.03%
South Africa	0.03%
New Zealand	0.03%
Taiwan	0.02%
Mexico	0.02%
Brazil	0.01%
India	0.01%
Slovenia	0.01%
Cayman Islands	0.01%

Based on 1000 largest holdings

Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).

Employees

6,400

Sector

Pharmaceuticals

More about the company